Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Abstract Background The resistance of lung cancer to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is one of the unconquered frontiers in chemotherapy. Mitogen-inducible gene 6 (Mig-6) is known to inhibit the kinase activity of epidermal growth factor receptor (EGFR). Similar...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2020-06-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s12885-020-07057-z |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
